Search by Drug Name or NDC

    NDC 65862-0193-30 Fluoxetine 20 mg/1 Details

    Fluoxetine 20 mg/1

    Fluoxetine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is FLUOXETINE HYDROCHLORIDE.

    Product Information

    NDC 65862-0193
    Product ID 65862-193_0d4f11cd-3cc6-4865-a63b-9f68228fb182
    Associated GPIs 58160040000120
    GCN Sequence Number 046214
    GCN Sequence Number Description fluoxetine HCl CAPSULE 20 MG ORAL
    HIC3 H2S
    HIC3 Description SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRIS)
    GCN 16354
    HICL Sequence Number 001655
    HICL Sequence Number Description FLUOXETINE HCL
    Brand/Generic Generic
    Proprietary Name Fluoxetine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fluoxetine Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name FLUOXETINE HYDROCHLORIDE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078619
    Listing Certified Through 2024-12-31

    Package

    NDC 65862-0193-30 (65862019330)

    NDC Package Code 65862-193-30
    Billing NDC 65862019330
    Package 30 CAPSULE in 1 BOTTLE (65862-193-30)
    Marketing Start Date 2018-01-31
    NDC Exclude Flag N
    Pricing Information N/A